(MREO) Mereo Biopharma complete technical analysis [charts+indicators] | Buy/Sell Mereo Biopharma | (MREO) share price targets
Complete technical analysis of Mereo Biopharma (MREO) by charts plus indicators, forecast predictions and share price targets for Mereo Biopharma (MREO)
Mereo Biopharma trades in USA in N A sector.
10 day averaged volume of Mereo Biopharma is 764830
Date | Daily Closing Price | Open | High | Low | Volume |
30 Tue Apr 2024 | 3.05 | 2.75 | 3.09 | 2.71 | 2.065 times |
29 Mon Apr 2024 | 2.76 | 2.75 | 2.82 | 2.67 | 0.694 times |
26 Fri Apr 2024 | 2.74 | 2.81 | 2.81 | 2.73 | 0.735 times |
25 Thu Apr 2024 | 2.81 | 2.75 | 2.82 | 2.64 | 1.348 times |
24 Wed Apr 2024 | 2.78 | 2.76 | 2.89 | 2.76 | 0.978 times |
23 Tue Apr 2024 | 2.78 | 2.81 | 2.85 | 2.75 | 1.033 times |
22 Mon Apr 2024 | 2.79 | 2.73 | 2.81 | 2.62 | 1.392 times |
19 Fri Apr 2024 | 2.64 | 2.62 | 2.67 | 2.53 | 1.193 times |
18 Thu Apr 2024 | 2.65 | 2.56 | 2.68 | 2.53 | 1.065 times |
17 Wed Apr 2024 | 2.58 | 2.70 | 2.71 | 2.58 | 0.786 times |
Stock of Mereo Biopharma (MREO) has showed a significant upmove. This could be a good time to enter in this stock!
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 3.1 as stoploss in an intra day sell trade for a target of 2.88. However, stock will show a bullish move above 3.1.
Share price targets for Mereo Biopharma (MREO)
Target Type | Value |
Downside Target | 1.95 |
Downside Target | 2.23 |
Downside Target | 2.45 |
Downside Target | 2.53 |
Downside Target | 2.62 |
Downside Target | 2.86 |
Upside Target | 3.09 |
Upside Target | 3.18 |
Upside Target | 3.27 |
Upside Target | 3.43 |
Upside Target | 3.48 |
Upside Target | 4.07 |
Upside Target | 4.18 |
Upside Target | 4.36 |
Intraday share price targets for Mereo Biopharma (MREO)
Target Type | Value |
Downside Intraday Target | 2.78 |
Downside Intraday Target | 2.52 |
Upside Intraday Target | 3.2 |
Upside Intraday Target | 3.36 |
Downside Intraday Target | 2.94 |
Weekly technical analysis of Mereo Biopharma (MREO)
Date | Weekly Closing Price | Open | High | Low | Volume |
30 Tue Apr 2024 | 3.05 | 2.75 | 3.09 | 2.67 | 0.503 times |
26 Fri Apr 2024 | 2.74 | 2.73 | 2.89 | 2.62 | 1.006 times |
19 Fri Apr 2024 | 2.64 | 2.68 | 2.72 | 2.53 | 0.8 times |
12 Fri Apr 2024 | 2.72 | 3.27 | 3.27 | 2.64 | 1.28 times |
05 Fri Apr 2024 | 3.29 | 3.35 | 3.48 | 3.18 | 0.81 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Mereo Biopharma (MREO)
Date | Monthly Closing Price | Open | High | Low | Volume |
30 Tue Apr 2024 | 3.05 | 3.35 | 3.48 | 2.53 | 0.765 times |
28 Thu Mar 2024 | 3.30 | 3.79 | 4.07 | 2.86 | 0.795 times |
29 Thu Feb 2024 | 3.80 | 3.80 | 4.36 | 3.43 | 0.61 times |
31 Wed Jan 2024 | 3.79 | 2.33 | 4.18 | 2.23 | 3.424 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Mereo Biopharma (MREO)
Price action analysis of Mereo Biopharma ( (MREO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Mereo Biopharma ( (MREO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Mereo Biopharma ( (MREO) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Mereo Biopharma ( (MREO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Mereo Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Mereo Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Mereo Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Mereo Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Mereo Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.79 and Mereo Biopharma (MREO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Mereo Biopharma (MREO) stock. Volume based technical analysis of Mereo Biopharma (MREO) stock is negative.
Mereo Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Mereo Biopharma ( (MREO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Mereo Biopharma ( (MREO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Mereo Biopharma ( (MREO) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Mereo Biopharma ( (MREO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Mereo Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Mereo Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Mereo Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Mereo Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Mereo Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.79 and Mereo Biopharma (MREO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Mereo Biopharma (MREO) stock. Volume based technical analysis of Mereo Biopharma (MREO) stock is negative.
Mereo Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.